The time of day of immunotherapy infusions does appear to affect patient outcomes. But convincing the wider oncology ...

In Unreliable: Bias, Fraud, and the Reproducibility Crisis in Biomedical Research, published next week by Columbia University ...

Plus: The startups landing spacecraft on the Moon, re-engineering immune cells to fight cancer, why you should warm up your ...

Combination treatment with nivolumab and cabozantinib provides long-term benefits over sunitinib in patients with advanced RCC, according to final results from the CheckMate 9ER trial.

A new study from Memorial Sloan Kettering Cancer Center shows good results for patients with pancreatic cancer. They used a ...